CD6: Difference between revisions
CSV import |
CSV import |
||
| Line 25: | Line 25: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 06:06, 17 March 2025
CD6 is a protein that in humans is encoded by the CD6 gene. CD6 is a type of cell surface receptor that is expressed on T cells and plays an important role in immune response and lymphocyte activation.
Structure[edit]
CD6 is a type 1 transmembrane glycoprotein that consists of a 24-amino acid signal peptide, a 398-amino acid extracellular domain, a 28-amino acid transmembrane domain, and a 76-amino acid cytoplasmic domain. The extracellular domain contains three scavenger receptor cysteine-rich (SRCR) domains, which are involved in protein-protein interactions.
Function[edit]
CD6 serves as a co-stimulatory molecule during T cell activation and also plays a role in T cell differentiation and proliferation. It interacts with CD166, also known as activated leukocyte cell adhesion molecule (ALCAM), on antigen-presenting cells, which helps to strengthen the adhesion between T cells and antigen-presenting cells during immune response.
Clinical significance[edit]
Alterations in the expression or function of CD6 have been associated with various autoimmune diseases, including rheumatoid arthritis, multiple sclerosis, and psoriasis. Therefore, CD6 is considered a potential therapeutic target for the treatment of these diseases. Several monoclonal antibodies targeting CD6 are currently being developed and tested in clinical trials.
See also[edit]
References[edit]
<references />
